Australia markets open in 9 hours 59 minutes

  • ALL ORDS

    7,282.10
    -45.90 (-0.63%)
     

  • AUD/USD

    0.7785
    +0.0027 (+0.35%)
     

  • ASX 200

    7,017.80
    -47.80 (-0.68%)
     

  • OIL

    63.31
    -0.07 (-0.11%)
     

  • GOLD

    1,773.40
    +2.80 (+0.16%)
     

  • BTC-AUD

    72,393.26
    -763.02 (-1.04%)
     

  • CMC Crypto 200

    1,277.42
    +43.01 (+3.48%)
     
Sign up here 📩:

Get the latest business, economy and property news, delivered straight to you.

Stay informed every day with Yahoo Finance's free Fully Briefed newsletter.

Global Clinical Genomics Market Report 2021 - The Interplay Between Clinical Research & Clinical Diagnostics - ResearchAndMarkets.com

·9-min read

The "Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics" report has been added to ResearchAndMarkets.com's offering.

This new, qualitative report provides an in-depth analysis across the complex, multi-step clinical genomics data process (which includes genomic data generation, data flow, and data warehousing), clinical genomics data solution providers, market trends, technologies impacting clinical genomics applications development, clinical genomics adoption challenges, and detailed challenges & needs analysis as identified in discussions with clinical end-users.

The report is unique, in that it is not a predictive market research report, but rather builds on data gathered from many end-user interviews combined with an extensive analysis of the clinical genomics sector.

Market Insights

Leading medical organizations have established precision medicine programs that support personalized patient treatment. Implementation of clinical genomics applications and enterprise-wide clinical data warehouses are considered the foundation for successful genomic medicine programs. Innovative technological advancements have allowed us to sequence and uncover mutational events at an unprecedented scale while facilitating linking genomic data to high-quality clinical data and diagnosis. Medical organizations understand the benefit of being empowered by data-driven approaches to reduce operational costs and time and to provide researchers and clinicians what is necessary to decipher critical research data and data for clinical decision making. However, technical and scientific limitations still need to be addressed for optimized and universal use of various data sources for both clinical and research purposes.

While data production is no longer a challenge, and targeted panels - and to some extent, whole-exome sequencing - are well adopted, the expected dramatic rise in whole-genome sequencing will result in unforeseeable quantities of data at the clinical level that needs to be managed, understood, and communicated. Low-cost sequencing of whole genomes at population scale is already in existence, but not yet widespread in the clinic, as many observed changes at the genome level cannot yet be fully interpreted or explain an existing phenotype. Scalable, fully automated analysis and knowledge extraction solutions incorporating rich annotation information are necessary to overcome these challenges. With massive quantities of NGS data (linked to different clinical and other types of data), artificial intelligence and machine learning are hailed as pivotal solutions to address the data interpretation and knowledge extraction challenges and to advance the clinical application of genomics.

Despite increasing efforts and investments in implementing clinical applications and building data solutions, many organizations are still challenged with the multi-faceted complexities in transforming to become data-driven. Implementations are challenged by ineffective data sharing, scalability and automation issues, non-optimized data generation and data flow approaches and non-standardized data from numerous sources. Implementing a complex clinical data warehouse presents many challenges starting with the various data sources it needs to support and the tools required to view the clinical information. Ingestion of data of different types and origins with relevant metadata; data transformation, standardization, and cleansing to support the needs of a diverse set of end-users in both the clinical and research settings; and varied end-users with individual needs and computation capabilities are all important considerations.

Clinical interviews detailed challenges associated with creating a workflow that incorporates a clinical data warehouse connecting clinical research with clinical diagnostics and vice versa. This important workflow leads to efficient clinical decision-making and reporting findings between clinical research and the clinic, which can optimize clinical outcomes and patient treatment.

Report Scope

This report provides an in-depth analysis of differences in product characteristics related to data processing, analysis, knowledge extraction and reporting of findings (including the type of content integrated for meaningful extraction), and compliance and security mechanisms. Both clinical end-users and commercial companies who require insight into this expanding industry and its providers and products will benefit from the critical, investigative, and qualitative report.

To create this robust comparison, the publisher researched these questions:

  • What are the current implementation choices of data solutions and testing services at leading medical organizations;

  • What are the unmet needs and challenges of medical organizations/clinical end-users in relation to clinical genomics implementation;

  • What are current clinical genomics market trends, and what innovations/technologies impact the adoption of clinical genomics applications;

  • Who are the key commercial data solution providers and what solutions/products do they offer;

  • Who are the genetic testing service providers and what specific services do they provide; and

  • What needs do the genomics data management, process, analysis and interpretation commercial companies address with what product capabilities, and how do they compare across the ecosystem of solution providers?

End-user interviews (N=21)

Conducted to understand the medical industry and clinical end user's needs and challenges, commercial solution preferences, and challenges with clinical data and integrating and communicating findings via an electronic healthcare system with the physician and the patient.

Meta-Data analysis

Performed a deep-dive interrogation of individual software, platform solutions, and genetic testing providers with publicly available information on the WWW [scientific publications, presentations, annual reports, white papers, and use cases].

Deep level analysis:

  • Researched implemented clinical genomics workflows at leading medical organizations (N=14) to support their internal precision medicine efforts.

  • Evaluated key commercial software and platform providers (N=18) of clinical genomics solutions, such as scaled data storage and computing solutions, and data analysis and interpretation to understand product focus, capabilities, and the strategy to address end-user needs.

  • Researched optimal genomic data generation, data flow, and intelligence data platform requirements that support the interplay between clinical research and clinical genomics.

  • Evaluated commercial players (N=8) implementing artificial intelligence/machine learning applications for clinical genomics.

Company/product profiles

Reviewed key companies with comprehensive solutions across the entire Clinical Genomics Workflow, including genetic testing/diagnostics service providers (N=20), their product focus, offered capabilities, and their strategy to address end-user needs, and more.

Key representative input:

Interviewed company representatives of established software suppliers to learn about current and future product solutions.

The 280-page report consists of 20 comprehensive Company Profiles of leading commercial companies across the entire workflow [BC Platforms, Bluebee, Color, Congenica, DNAnexus, Fabric Genomics, Foundation Medicine, Freenome, Genoox, Genuity Science, Google Life Sciences, GRAIL, Helix, Illumina (with BaseSpace), Invitae, PierianDx, QIAGEN, Seven Bridges Genomics, SOPHiA Genetics, and Tempus - includes company metrics, funding sources, product details, founder/executive and board information, additional notes, and company visions].

Key Topics Covered

1. THE CLINICAL DIAGNOSTICS & MOLECULAR PROFILING WORKFLOW

  • Clinical Genomics Workflow End Users/Personas

  • Mapping End Users to the Clinical Genomics Workflow

  • Clinical Information Delivery

2. THE PRECISION MEDICINE VALUE CHAIN

3. LEADING MEDICAL ORGANIZATIONS PLATFORM AND INFRASTRUCTURE PREFERENCES IN SUPPORT OF THEIR CLINICAL GENOMICS WORKFLOWS

  • Implementations and Choices of Molecular Profiling and Genetic Testing Processes

  • Medical Organizations' Clinical Genetic Testing Labs

  • Testing Lab Selection Criteria

  • Platforms and Infrastructures Currently Implemented at Leading Medical Organizations

  • Adoption of Commercial and Internally Developed Platforms, Tools, and Services

  • Medical Organizations Platform and Infrastructure Preferences

  • Profiles of Leading Medical Organizations

  • Cedars-Sinai

  • Emory Healthcare

  • Geisinger Health Systems

  • Intermountain Healthcare

  • Kaiser Permanente

  • Mayo Clinic

  • MD Anderson Cancer Center

  • Moffitt Cancer Center

  • Mount Sinai Health System

  • Nationwide Children's Hospital

  • Partners HealthCare

  • Sanford Health

  • St. Jude Children's Hospital

  • Vanderbilt University Medical Center

4. MEDICAL INDUSTRY CHALLENGES

  • Clinical Genomics - Unmet Needs and Challenges

  • Technical Challenges Associated with Scaling Clinical Genomics Applications

  • Scientific Challenges Associated with the Implementation of Clinical Genomics

  • Non-Technical / Scientific Challenges Associated with the Implementation of Clinical Genomics Applications

5. GENOMIC DATA GENERATION, DATA FLOW, AND DATA WAREHOUSING

  • Rethinking Optimized Genomic Data Generation and Data Flow

  • Structures of Successful Big Data Platforms

  • Scalable Data Generation and Data Flow Lacking Data Standards

  • Slow Integration of Clinical Genomics Data with Other Clinical/Patient Data

  • Current EMR/EHR Systems Do Not Support Genomics Data

  • Variant Data Warehousing for Data Analysis, Mining, and Querying

  • Enterprise Data Platform Architecture

  • Integration of Various Types of Data

  • A Data Warehouse That Supports Clinical Research

  • Data Warehousing and Fast Data Processing Requires a Scalable Infrastructure

  • The Ideal Variant Data Analysis and Query Platform

  • Data Warehouse versus a Data Lake

  • Cloud Is the Preferred Infrastructure

6. CLINICAL GENOMICS DATA SOLUTIONS

  • Genomic Data Infrastructures/Platforms for Data Storage, Processing, and Analysis

  • Scaled Data Storage and Computing Solutions

  • Clinical Genomics Data Platforms

  • Integrated Genomic Workflow

  • Data Processing Speed, Scalability, and Flexibility

  • Clinical Data Management & Knowledge Extraction

  • Clinico-Genomic Data Management and Integration

  • Genomic/Variant Data Querying and Analysis

  • Variant Data Interpretation/Decision Making/Reporting

  • Tertiary Analysis - Sequence Data Interpretation and Insight Generation

  • Tertiary Analysis - Embedded Interpretation Content for Insight Generation

  • Data Processing, Knowledge Extraction, and Reporting Companies Side-by-Side

7. CLINICAL GENOMICS MARKET TRENDS

  • Factors Impacting Clinical Sequencing Adoption

  • Genetic Testing and Molecular Profiling Trends

  • The Increasing Trend of Clinical Genetic Testing

  • Clinical Genomics Applications to Be Established in the Clinic as a Routine

  • Routine Genomic Applications Established over the Next Three to Five Years

  • Requirements to Establish Genomic Applications as a Routine

  • Mergers, Acquisitions, and Partnerships Accelerate Adoption of Clinical Genomics

  • Agilent Is Building Integrated, Complete Clinical Workflow Solutions

  • Illumina's M&As Suggest the Goal of a Fully Integrated Sequencing Solution

  • Roche Is Expanding its Diagnostics Business

  • Thermo Fisher Scientific Is Strengthening Its Presence in the Clinical Sector

  • QIAGEN Is Pushing the Molecular Diagnostics and Clinical Research Markets

  • Other Acquisitions and Partnerships

8. TECHNOLOGIES IMPACTING THE IMPLEMENTATION OF CLINICAL GENOMICS & MOLECULAR PROFILING APPLICATIONS

  • 3rd and 4th Generation Sequencing Technology

  • Artificial Intelligence/Machine Learning Applications

  • AI in Healthcare Adoption Drivers

  • Liquid Biopsy in Clinical Diagnostics

  • Liquid Biopsy Clinical Applications

  • Long-Read Sequencing Technology

  • Real-World Data / Real-World Evidence

  • The FDA Is Attempting to Define RWD and RWE

  • An Uptick of RWD and RWE Publications

  • The Benefits of Real-World Evidence

  • The Challenges of Using RWD and RWE

  • An Active Playing Field of Commercial RWD Players

  • Clinical Genomics Adoption Challenges

9. COVID-19, THE HEALTHCARE DISRUPTER

  • Diagnostics - Commercial Companies Revamping

  • Diagnostics Companies Quickly Pivoted

  • COVID-19, a Disrupter, but also an Opportunity

  • Viral Sequencing Reveals How SARSCo-V-2 Evolves and Spreads

  • COVID-19 Resulted in Unprecedented Data Sharing

  • COVID-19 and the Massive Disruptions to Clinical Trials Processes

10. COMMERCIAL CLINICAL SOLUTIONS / PRODUCT PROVIDERS

  • Company Profiles

  • BC Platforms

  • Bluebee (an Illumina company)

  • Color

  • Congenica

  • DNAnexus

  • Fabric Genomics

  • Foundation Medicine

  • Freenome

  • Genoox

  • Genuity Science

  • Google Life Sciences

  • GRAIL

  • Helix

  • Illumina

  • Invitae

  • PierianDx

  • QIAGEN

  • Seven Bridges

  • SOPHiA Genetics

  • Tempus

11. THE FUNDING SITUATION

Companies Mentioned

  • Agilent

  • BC Platforms

  • Bluebee (an Illumina company)

  • Cedars-Sinai

  • Color

  • Congenica

  • DNAnexus

  • Emory Healthcare

  • Fabric Genomics

  • Foundation Medicine

  • Freenome

  • Geisinger Health Systems

  • Genoox

  • Genuity Science

  • Google Life Sciences

  • GRAIL

  • Helix

  • Illumina

  • Intermountain Healthcare

  • Invitae

  • Kaiser Permanente

  • Mayo Clinic

  • MD Anderson Cancer Center

  • Moffitt Cancer Center

  • Mount Sinai Health System

  • Nationwide Children's Hospital

  • Partners HealthCare

  • PierianDx

  • QIAGEN

  • Roche

  • Sanford Health

  • Seven Bridges

  • SOPHiA Genetics

  • St. Jude Children's Hospital

  • Tempus

  • Thermo Fisher Scientific

  • Vanderbilt University Medical Center

For more information about this report visit https://www.researchandmarkets.com/r/avdtf6

View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005494/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Latest stories

  • Global Wearable Payment Device Market (2021 to 2026) - Security Concerns Related to Wearable Payment Devices Presents Opportunities - ResearchAndMarkets.com

    The "Global Wearable Payment Device Market with COVID-19 Impact Analysis by Device Type (Smart Watches, Fitness Trackers), Technology (NFC, RFID), Sales Channel, Application (Retail/Grocery Stores, Restaurants, Entertainment Centers), and Geography - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

  • Growing Cloud Adoption Fuels Americas Sourcing Market in Q1, ISG Index® Shows

    Americas demand for cloud-based services reached a record high in Q1, but managed services produced mixed results, the ISG Index (Nasdaq: III) found.

  • The travel bubble rule that could see Aussies JAILED if broken

    A travel bubble 'loophole' that gives Australians easier access to international destinations could land reckless travellers in jail.

  • AutoNation CEO Says Chip Shortage Could Drag On for a Year

    (Bloomberg) -- The global semiconductor shortage that’s crippling the auto industry could drag on for as long as a year, according to Mike Jackson, chief executive officer of AutoNation Inc., the largest car-dealer chain in the U.S.AutoNation expects the industry’s vehicle shipments in the second quarter to be double what they were a year ago, but that’s barely enough to keep dealer lots full, Jackson, 72, said in an interview.“The supply chain is fragile and disrupted because of the chip shortages and still dealing with the pandemic,” he said.Low interest rates, stimulus checks, and a desire for private transportation during the pandemic are fueling demand for vehicles, while assembly plants are sitting idle because of a lack of chips. AutoNation has been increasing used-car sales to make up for the lack of new supply.“I see it continuing for at least the next year, the extraordinary demand, and I see no resolution on the microchip side for six to nine months, or a year,” Jackson said.AutoNation posted adjusted earnings from continuing operations of $2.79 a share in the first quarter, more than triple a year ago and ahead of analysts’ estimates. Revenue from existing stores grew 27% to $5.9 billion, also beating projections.More than half of AutoNation’s sales now originate online, Jackson said, helping to cut costs and juice profit as vehicle demand has rebounded.The company’s shares pared an early gain of as much as 2.3%, trading up less than 1% to $97.84 at 9:53 a.m. in New York. The stock is up about 40% so far this year.(Updates share activity in eighth paragaph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Soccer-Milan CEO insists Super League will be good for football

    AC Milan chief executive Ivan Gazidis said on Tuesday that the proposed breakaway Super League will be good for the club and for whole of football. Milan are one of three Italian clubs, along with three teams from Spain and six from England, to have announced on Sunday that they want to be part of a new European Super League, which will run in competition with the UEFA Champions League. "We're confident that this new competition will capture the imagination of billions of soccer fans all over the world and will be a new, exciting chapter for the game," Gazidis wrote in a letter to Milan's sponsors and commercial partners.

  • Perficient Wins Red Hat North American Partner of the Year Award

    Perficient named the Application Platform Success Partner of the Year by Red Hat, Inc.

  • Cannabis Extract Market Research Report by Product, by Type - Global Forecast to 2025 - Cumulative Impact of COVID-19

    Cannabis Extract Market Research Report by Product (Oils and Tinctures), by Type (Cannabis Isolates and Full Spectrum Extracts) - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, April 20, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cannabis Extract Market Research Report by Product, by Type - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06063015/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Cannabis Extract Market is expected to grow from USD 2,193.67 Million in 2020 to USD 4,792.67 Million by the end of 2025.2. The Global Cannabis Extract Market is expected to grow from EUR 1,923.45 Million in 2020 to EUR 4,202.30 Million by the end of 2025.3. The Global Cannabis Extract Market is expected to grow from GBP 1,709.95 Million in 2020 to GBP 3,735.85 Million by the end of 2025.4. The Global Cannabis Extract Market is expected to grow from JPY 234,121.12 Million in 2020 to JPY 511,499.33 Million by the end of 2025.5. The Global Cannabis Extract Market is expected to grow from AUD 3,185.51 Million in 2020 to AUD 6,959.59 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Cannabis Extract to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Product , the Cannabis Extract Market studied across Oils and Tinctures. Based on Type, the Cannabis Extract Market studied across Cannabis Isolates and Full Spectrum Extracts. Based on Geography, the Cannabis Extract Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cannabis Extract Market including ABcann Medicinals, Inc., Aphria, Inc, Aurora Cannabis Inc., British American Tobacco PLC, Canopy Growth Corporation., CBD American Shaman, Folium Biosciences, GW Pharmaceuticals, PLC By Jazz Pharmaceuticals, Indiva Limited, JULABO GmbH, Kynd Cannabis Company, Medical Marijuana, Inc., Medicine Man Technologies, Inc, NuLeaf Naturals, LLC, Optimum Extracts, Organigram Holding, Inc., Peridot Labs, PharmaHemp, The Cronos Group, Tikun Olam, Ltd. by Cannbit Pharmaceuticals, Tilray, VIVO Cannabis Inc, and Wayland Group Corp.. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cannabis Extract Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Cannabis Extract Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cannabis Extract Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cannabis Extract Market?4. What is the competitive strategic window for opportunities in the Global Cannabis Extract Market?5. What are the technology trends and regulatory frameworks in the Global Cannabis Extract Market?6. What are the modes and strategic moves considered suitable for entering the Global Cannabis Extract Market?Read the full report: https://www.reportlinker.com/p06063015/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • 2021 NFL draft: USC's Alijah Vera-Tucker is OG1, but should he play tackle?

    Our countdown of the top 100 prospects in the 2021 NFL draft continues with No. 13 — the Trojans' undersized but highly effective blocker who projects to two positions.

  • Options on Coinbase Global start trading on U.S. exchanges

    Options on Coinbase Global Inc started trading on Tuesday, less than a week after the U.S. cryptocurrency exchange's closely watched market debut on Nasdaq. Monthly options contracts on Coinbase shares started trading for the first time on all U.S. options exchanges, including ones run by Cboe Global Markets, the Nasdaq and the Intercontinental Exchange, on Tuesday. Nearly 1,000 Coinbase options contracts changed hands in the first 10 minutes of trading, with calls outnumbering puts slightly, data from options analytics firm Trade Alert showed.

  • The Worldwide Ultrasonic Testing Industry is Estimated to Reach $4.2 Billion by 2026 at a CAGR of 7.1% from 2021 - ResearchAndMarkets.com

    The "Ultrasonic Testing Market with COVID-19 Impact by Type (Time-of Flight Diffraction, Immersion Testing), Equipment (Flaw Detectors, Imaging System, and Bond Testers), Service, Vertical, and Geography - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

  • Huge crowds flock to Vietnamese religious festival

    As many as 30,000 people were expected to visit the Hung Kings temple on each of the three days of the festival, provincial authorities said.The event commemorates the anniversary of the death of the first king who founded Vietnam some 4,000 years ago, Lac Long Quan.Vietnam has only reported 35 coronavirus deaths since the pandemic began. At the temple site, there were preventative measures in place, including hand sanitizer at entrances and police ensuring people kept wearing face masks.

  • DogeDay hashtags help meme-based cryptocurrency Dogecoin hit new high

    Dogecoin prices hit an all-time on Tuesday, with a market capitalisation above $50 billion, after social media fans used hashtags to fuel a rally in the meme-based cryptocurrency. An 8,000% price surge this year has seen Dogecoin, which was launched as a satirical critique of 2013's cryptocurrency frenzy, overtake more widely-used cryptocurrencies like Tether to become the fifth-largest coin. While Dogecoin, whose logo features a Shiba Inu dog at the centre of the meme, a represents only a fraction of bitcoin's $1 trillion value, it can be traded on crypto exchanges and more popular mainstream trading apps.

  • Insurance Analytics Market by Component, Application, Deployment Mode, Organization Size, End-user and Region - Global Forecast to 2026 - ResearchAndMarkets.com

    The "Insurance Analytics Market by Component (Tools and Services), Application (Claims Management, Risk Management, Customer Management and Personalization, Process Optimization), Deployment Mode, Organization Size, End User, and Region - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

  • Waterville Valley Resort Announces New Bartholet 6-Person Detachable Bubble Lift

    Waterville Valley, NH, April 20, 2021 (GLOBE NEWSWIRE) -- Waterville Valley Resort is pleased to announce the signing of a contract for a new 6-person detachable bubble lift in partnership with MND Ropeways. The new lift will replace the 1988 White Peaks Express Quad, the first detachable high-speed quad in New Hampshire. This will be one of the largest upcoming lift projects in the Northeast and the first of its kind in the United States. This project will be installed over two construction seasons and will open for the 2022/23 ski season. “We have developed a strong partnership with MND over the last 4 years, including the installation of conveyors, a surface lift, and significant snowmaking upgrades and are excited to continue to work with them as a strategic partner for this project,” said Tim Smith, President/General Manager of Waterville Valley Resort. “Replacing our White Peaks lift is the most important project in our investment plan for the existing resort footprint and will continue our work to enhance the guest experience at Waterville Valley Resort.” The Bartholet 6-person bubble features the best technology in the market today and has undergone in-depth testing to ensure that it is the right solution for Waterville Valley Resort. The new chairlift will increase transport capacity to 3,000 people per hour and offer both comfort and reliability with the latest 6-person bubble seats Design by Porsche Design Studio. The lift components will provide a much more comfortable guest experience on windy and cold days. The chair, bubble, and lift profile have been specifically designed for the mountain’s location and features, which will make it less susceptible to wind holds. "This project will expand our position in the U.S. market by building our first detachable ropeway transportation system in the United States,” said Xavier Gallot-Lavallée, Chairman and CEO of MND. “North American resorts are demonstrating their willingness to renew their offerings by investing in safety, comfort and customer experience. Waterville Valley is a perfect example of this approach, and our teams are mobilized to support these developments with our technology and service offerings." ### About Waterville Valley Resort Waterville Valley is a four-season resort set on 540 private acres surrounded by 360° of National Forest. Sitting atop the 4,004-foot Mt. Tecumseh, “New Hampshire’s Family Resort” features 265 acres of skiable terrain, a vertical drop of 2,020 feet, 62 trails, 12 lifts, and 74k of groomed Nordic terrain and dining in the Town Square as well as a variety of lodging options, including country inns, condominiums, and all-suite hotels. For more information visit waterville.com. About MND MND is a French industrial group specializing in ropeway mobility, snowmaking systems, mountain safety and sensational leisure infrastructures. With more than 3,000 customers in 49 countries, MND contributes daily to the mobility, leisure and safety of all by offering proven and sustainable solutions based on its experience in the mountains. Based in Savoie, France, MND has 300 employees and relies on 7 international distribution subsidiaries and 28 distributors to develop its activities worldwide. MND is listed on the Euronext Growth market in Paris (FR0011584549 - ALMND). Learn more: www.mnd.com About MND in the United States MND has been present in the United States for 10 years with a Western office located in Eagle, Colorado and an Eastern office in Laconia, New Hampshire. In the United States, MND is present in avalanche risk prevention, snowmaking systems, ski lifts and ski area safety equipment. Attachments ropeways-chairs-waterville-nonbinding ropeways-base-waterville-nonbinding CONTACT: Stacie Waterville Valley Resort 603-236-84311 x 3204 ssullivan@waterville.com

  • Global Enterprise Data Management Market to Exceed $136.4 Billion and Rise at a CAGR of 10.5% during the Covid-19 Mayhem – Exclusive Report with COVID-19 Impact Analysis by Research Dive

    The global enterprise data management market is expected to surge during the Covid-19 pandemic. EDM (Enterprise Data Management) offers key advantages such as multi-user capabilities and strategic management of administration information.New York, USA, April 20, 2021 (GLOBE NEWSWIRE) -- As per the latest report offered by Research Dive, the global enterprise data management market is anticipated to generate a revenue of $136.4 billion by 2026, increasing from $62.3 billion in 2018, at a growth rate of 10.5% during 2019-2026 timeframe. Download Free Sample Report of the Global Enterprise Data Management Market: https://www.researchdive.com/download-sample/269 The report elucidates in-depth analysis on the impact of COVID-19 pandemic on the current and upcoming rise of the industry worldwide, by analyzing prominent factors such as main drivers and key limitations, trends and advances, regional market scenario, and size and scope of the market during the pandemic. The report also mentions that the COVID-19 pandemic has hindered the market growth globally. Check out How COVID-19 impacts the Global Enterprise Data Management Market. Click here to Speak with Our Analyst: https://www.researchdive.com/connect-to-analyst/269 Factors Affecting the Market during the Covid-19 Mayhem EDM (Enterprise Data Management) offers key advantages such as multi-user capabilities, strategic management of administration information, and enhanced gauging abilities. Moreover, EDM provides a unified database system that hands out controlled access to the users and enables simple data management. These all factors are predicted to boost the growth of the global market during the estimated timeframe. However, downtime risks and loss of data are expected to hinder the market growth in the forecast period. "COVID-19 disaster has enforced a positive impact on the global enterprise data management market growth." Key Highlights of the Market: 1. The predicted CAGR of the enterprise data management market, prior to the outbreak of the COVID-19 pandemic, was 9.3% during the analyzed period. 2. The enterprise data management industry CAGR worldwide, as projected after the onset of the new coronavirus mayhem, is estimated to be 10.5% during the forecast time period. 3. The market share of the enterprise data management industry in 2020, as anticipated before the COVID-19 crises began, was accounted for $74.1 billion. 4. The current market size of the enterprise data management market in 2020, after experiencing the COVID-19 outbreak, is $76.0 billion. Check out all Information and communication technology & media Industry Reports: https://www.researchdive.com/information-and-communication-technology-and-media Current Scenario of the Market during the Covid-19 Pandemic The EDM system has the potential to combine inhabitant estimates via school conscription, tax information, and nation documentation to track down families and individuals that are vulnerable to the Covid-19 pandemic. Moreover, this system is assisting local government bodies and service organizations to avert over-counting of vulnerable people. These features are considered to fuel the market growth during the pandemic. Future Scenario of the Market The enterprise data management market is projected to provide additional growth during the Covid-19 outbreak and the entire forecasted timeframe. EDM systems are used for backing up healthcare segment by optimizing resources. Furthermore, this system identifies hotspot areas and the occurrence of the outbreak, so that healthcare facilities can prep up ICU beds and ventilators for treatment purposes. Access Varied Market Reports Bearing Extensive Analysis of the Market Situation, Updated With The Impact of COVID-19: https://www.researchdive.com/covid-19-insights Top Key Players 1. Teradata Corporation2. SAP SE3. SAS Institute Inc.4. Micro Focus International PLC5. Orcale Corporation6. IBM Corporation7. Amazon Web Services8. Talend9. Cloudera10. Golden Source Corporation These market players are focusing on several strategies such as product revelations, research & development, and acquisitions of businesses for the market growth. For instance, in September 2020, Cloudera, a software company, announced the launch of enterprise data cloud services on Cloudera data platform. The new services are developed for analysts, data engineers, and scientists. The service also includes CDP operational database, CDP data engineering, and CDP data visualization. The report also summarizes many important aspects including financial performance of the key players, SWOT analysis, product portfolio, and latest strategic developments. Click Here to Get Absolute Top Companies Development Strategies Summary Report. TRENDING REPORTS WITH COVID-19 IMPACT ANALYSIS 1. Remote Access Software Market– Global Opportunity Analysis and Industry Forecast, 2019–2026 – Request to Download Free Sample Report 2. Field Mobility Solution Market: Global Opportunity Analysis and Industry Forecast, 2019–2026 – Request to Download Free Sample Report 3. Pipeline Security Market: Global Opportunity Analysis and Industry Forecast, 2019–2026 – Request to Download Free Sample Report 4. Workforce Management Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 – Request to Download Free Sample Report 5. Mobile Satellite Phone Market: Global Opportunity Analysis and Industry Forecast, 2019-2027 - Request to Download Free Sample Report CONTACT: Mr. Abhishek Paliwal Research Dive 30 Wall St. 8th Floor, New York NY 10005 (P) +91-(788)-802-9103 (India) +1-(917)-444-1262 (US) Toll Free: 1-888-961-4454 E-mail: support@researchdive.com Website: https://www.researchdive.com Blog: https://www.researchdive.com/blog/ LinkedIn: https://www.linkedin.com/company/research-dive/ Twitter: https://twitter.com/ResearchDive Facebook: https://www.facebook.com/Research-Dive-1385542314927521

  • Global Public Health Data Standard to Enable Vaccine Certification Interoperability

    CDISC and Learning Health Community collaborate on global public health data standard to enable success of vaccine credentialing applications.

  • Centrist Kate Middleton is nailing it as the person to unite the warring royal party

    The dust is settling after a ceremony which marked the life of the Duke of Edinburgh, but also points the way to other transitions in the royal dynasty. Prince Charles is now in effect a “soft regent” with a more active chief executive role in palace affairs. The royal tribe remains fractious and competitive in the heart of an ongoing PR war with the Sussexes, unleashed by last month’s j’accuse interview, headlined by Meghan’s accusations of racism and cold-heartedness and Prince Harry’s airing of grudges against his father and brother.

  • Cannabidiol Market Research Report by Type, by Distribution Channel, by End-use - Global Forecast to 2025 - Cumulative Impact of COVID-19

    Cannabidiol Market Research Report by Type (Hemp and Marijuana), by Distribution Channel (B2B and B2C), by End-use - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, April 20, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cannabidiol Market Research Report by Type, by Distribution Channel, by End-use - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06063016/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Cannabidiol Market is expected to grow from USD 2,781.56 Million in 2020 to USD 5,802.67 Million by the end of 2025.2. The Global Cannabidiol Market is expected to grow from EUR 2,438.93 Million in 2020 to EUR 5,087.89 Million by the end of 2025.3. The Global Cannabidiol Market is expected to grow from GBP 2,168.21 Million in 2020 to GBP 4,523.15 Million by the end of 2025.4. The Global Cannabidiol Market is expected to grow from JPY 296,863.77 Million in 2020 to JPY 619,292.88 Million by the end of 2025.5. The Global Cannabidiol Market is expected to grow from AUD 4,039.20 Million in 2020 to AUD 8,426.26 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Cannabidiol to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Type, the Cannabidiol Market studied across Hemp and Marijuana. Based on Distribution Channel, the Cannabidiol Market studied across B2B and B2C. The B2C further studied across Hospital Pharmacies, Online, and Retail Stores. Based on End-use, the Cannabidiol Market studied across Medical, Personal Use, Pharmaceuticals, and Wellness. The Medical further studied across Cancer, Chronic Pain, and Mental Disorders. The Wellness further studied across Food & Beverages, Nutraceuticals, and Personal Care & Cosmetics. Based on Geography, the Cannabidiol Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cannabidiol Market including ABcann Medicinals, Inc., Aphria, Inc, Aurora Cannabis, Cannoid, LLC, Canopy Growth Corporation., CBD American Shaman, Cura CS, CV Sciences, Inc, Elixinol, ENDOCA, Folium Biosciences, GW Pharmaceuticals, plc, HempLife Today LLC, IrieCBD, Isodiol International, Inc., Kazmira LLC, Maricann, Inc., MEDICAL MARIJUANA, INC., Merck KGaA, NuLeaf Naturals, LLC, Organigram Holding, Inc., Pharmahemp d.o.o., Phyto Animal Health, Tikun Olam, and Tilray. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cannabidiol Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Cannabidiol Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cannabidiol Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cannabidiol Market?4. What is the competitive strategic window for opportunities in the Global Cannabidiol Market?5. What are the technology trends and regulatory frameworks in the Global Cannabidiol Market?6. What are the modes and strategic moves considered suitable for entering the Global Cannabidiol Market?Read the full report: https://www.reportlinker.com/p06063016/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Coronavirus deaths remain at six-month low as Easter affects registrations – ONS

    There were 379 deaths registered in the week ending April 2 in England and Wales where Covid-19 was mentioned on the death certificate.

  • Roth Unbound: A Writer and his Books by Claudia Roth Pierpont review

    Last year Philip Roth, now aged 80, told an interviewer for Le Monde that he had completely stopped writing fiction since publishing Nemesis in 2010. “I work for him, I’m his employee,” Roth said. In the meantime, here’s Roth Unbound, not quite a biography but nonetheless a chronological study of his writing career, with some startling biographical disclosures en route, which Roth has also supported.